197 related articles for article (PubMed ID: 12695356)
1. Toxicokinetics and metabolism of N-[(14)C]N-methyl-2-pyrrolidone in male Sprague-Dawley rats: in vivo and in vitro percutaneous absorption.
Payan JP; Boudry I; Beydon D; Fabry JP; Grandclaude MC; Ferrari E; André JC
Drug Metab Dispos; 2003 May; 31(5):659-69. PubMed ID: 12695356
[TBL] [Abstract][Full Text] [Related]
2. Influence of water dilution on percutaneous absorption of N-vinyl-2-pyrrolidone in vivo and ex vivo in rats and ex vivo in humans.
Marquet F; Payan JP; Beydon D; Wathier L; Ferrari E; Grandclaude MC
Arch Toxicol; 2015 Nov; 89(11):2007-14. PubMed ID: 25160662
[TBL] [Abstract][Full Text] [Related]
3. Toxicokinetics and metabolism of N-[14C]methylpyrrolidone in male Sprague-Dawley rats. A saturable NMP elimination process.
Payan JP; Beydon D; Fabry JP; Boudry I; Cossec B; Ferrari E
Drug Metab Dispos; 2002 Dec; 30(12):1418-24. PubMed ID: 12433813
[TBL] [Abstract][Full Text] [Related]
4. Contribution of CYP2E1 to N-methyl-2-pyrrolidone metabolism.
Ligocka D; Lison D; Haufroid V
Arch Toxicol; 2003 May; 77(5):261-6. PubMed ID: 12734639
[TBL] [Abstract][Full Text] [Related]
5. Effect of N-methyl-2-pyrrolidone on skin permeation of estradiol.
Koizumi A; Fujii M; Kondoh M; Watanabe Y
Eur J Pharm Biopharm; 2004 May; 57(3):473-8. PubMed ID: 15093595
[TBL] [Abstract][Full Text] [Related]
6. Human volunteer study on the influence of exposure duration and dilution of dermally applied N-methyl-2-pyrrolidone (NMP) on the urinary elimination of NMP metabolites.
Keener SA; Wrbitzky R; Bader M
Int Arch Occup Environ Health; 2007 Feb; 80(4):327-34. PubMed ID: 16897094
[TBL] [Abstract][Full Text] [Related]
7. In vivo and in vitro percutaneous absorption of [14C]pyrene in Sprague Dawley male rats: skin reservoir effect and consequence on urinary 1-OH pyrene excretion.
Payan JP; Lafontaine M; Simon P; Marquet F; Champmartin-Gendre C; Beydon D; Ferrari E
Arch Toxicol; 2008 Oct; 82(10):739-47. PubMed ID: 18421439
[TBL] [Abstract][Full Text] [Related]
8. Dermal absorption and urinary elimination of N-methyl-2-pyrrolidone.
Bader M; Keener SA; Wrbitzky R
Int Arch Occup Environ Health; 2005 Sep; 78(8):673-6. PubMed ID: 16001206
[TBL] [Abstract][Full Text] [Related]
9. In vivo and in vitro percutaneous absorption of [(14)C]di-N-butylphthalate in rat.
Payan JP; Marty JP; Fabry JP; Beydon D; Boudry I; Ferrari E; Canel F; Grandclaude MC; Vincent CM
Drug Metab Dispos; 2001 Jun; 29(6):843-54. PubMed ID: 11353753
[TBL] [Abstract][Full Text] [Related]
10. Role of n-methyl pyrrolidone in the enhancement of aqueous phase transdermal transport.
Lee PJ; Langer R; Shastri VP
J Pharm Sci; 2005 Apr; 94(4):912-7. PubMed ID: 15736187
[TBL] [Abstract][Full Text] [Related]
11. Dermal exposure to aqueous solutions of N-methyl pyrrolidone.
Akrill P; Cocker J; Dixon S
Toxicol Lett; 2002 Aug; 134(1-3):265-9. PubMed ID: 12191887
[TBL] [Abstract][Full Text] [Related]
12. Concentrations of N-methyl-2-pyrrolidone (NMP) and its metabolites in plasma and urine following oral administration of NMP to rats.
Carnerup MA; Saillenfait AM; Jönsson BA
Food Chem Toxicol; 2005 Sep; 43(9):1441-7. PubMed ID: 15951091
[TBL] [Abstract][Full Text] [Related]
13. In vivo percutaneous absorption of boric acid, borax, and disodium octaborate tetrahydrate in humans compared to in vitro absorption in human skin from infinite and finite doses.
Wester RC; Hui X; Hartway T; Maibach HI; Bell K; Schell MJ; Northington DJ; Strong P; Culver BD
Toxicol Sci; 1998 Sep; 45(1):42-51. PubMed ID: 9848109
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of exposure biomarkers from percutaneous absorption of N-methyl-2-pyrrolidone.
Akesson B; Carnerup MA; Jönsson BA
Scand J Work Environ Health; 2004 Aug; 30(4):306-12. PubMed ID: 15458014
[TBL] [Abstract][Full Text] [Related]
15. Human volunteer study on the inhalational and dermal absorption of N-methyl-2-pyrrolidone (NMP) from the vapour phase.
Bader M; Wrbitzky R; Blaszkewicz M; Schäper M; van Thriel C
Arch Toxicol; 2008 Jan; 82(1):13-20. PubMed ID: 17721780
[TBL] [Abstract][Full Text] [Related]
16. Human experimental exposure to N-methyl-2-pyrrolidone (NMP): toxicokinetics of NMP, 5-hydroxy- N-methyl-2-pyrrolidone, N-methylsuccinimide and 2-hydroxy- N-methylsuccinimide (2-HMSI), and biological monitoring using 2-HMSI as a biomarker.
Jönsson BA; Akesson B
Int Arch Occup Environ Health; 2003 May; 76(4):267-74. PubMed ID: 12684812
[TBL] [Abstract][Full Text] [Related]
17. Quantitative risk analysis for N-methyl pyrrolidone using physiologically based pharmacokinetic and benchmark dose modeling.
Poet TS; Kirman CR; Bader M; van Thriel C; Gargas ML; Hinderliter PM
Toxicol Sci; 2010 Feb; 113(2):468-82. PubMed ID: 19875680
[TBL] [Abstract][Full Text] [Related]
18. Effects of experimental conditions on absorption of glycol ethers through human skin in vitro.
Wilkinson SC; Williams FM
Int Arch Occup Environ Health; 2002 Oct; 75(8):519-27. PubMed ID: 12373313
[TBL] [Abstract][Full Text] [Related]
19. Experimental methods for determining permethrin dermal absorption.
Reifenrath WG; Ross JH; Driver JH
J Toxicol Environ Health A; 2011; 74(5):325-35. PubMed ID: 21240732
[TBL] [Abstract][Full Text] [Related]
20. Preparation of griseofulvin for topical application using N-methyl-2-pyrrolidone.
Fujii M; Bouno M; Fujita S; Yoshida M; Watanabe Y; Matsumoto M
Biol Pharm Bull; 2000 Nov; 23(11):1341-5. PubMed ID: 11085363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
